Bih‐Rong Wei

The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity

Ki-Eun Chang, Bih‐Rong Wei, James P. Madigan et al. · Molecular Cancer Therapeutics · 2014 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Bioluminescent imaging of drug efflux at the blood–brain barrier mediated by the transporter ABCG2

Joshua Bakhsheshian, Bih‐Rong Wei, Ki-Eun Chang et al. · Proceedings of the National Academy of Sciences · 2013 · 48 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Synergistic targeted inhibition of <scp>MEK</scp> and dual <scp>PI</scp>3K/<scp>mTOR</scp> diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma

Bih‐Rong Wei, Helen Michael, Charles Halsey et al. · Pigment Cell & Melanoma Research · 2016 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma

Bih‐Rong Wei, Shelley Hoover, Cody J. Peer et al. · Molecular Cancer Therapeutics · 2020 · 30 citations · Full text

Medicine, Oncology, Veterinary Dermatology +17

Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization

Bih‐Rong Wei, R. Mark Simpson · Clinical Biochemistry · 2013 · 29 citations · Full text

Medicine, Biomedical Informatics, Pathology +16